• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride: A Comprehensive Overview

N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride, with the CAS number 1337880-84-8, is a compound of significant interest in the field of pharmaceutical chemistry. This compound belongs to a class of molecules that have garnered attention due to their potential biological activities and structural features. The hydrochloride salt form enhances its solubility and stability, making it a valuable candidate for further research and development.

The structure of N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride incorporates a pyridazine ring substituted with a chlorine atom at the 6-position, a methyl group attached to the 3-position of the pyridazine ring, and an amine group connected to a cyclopropane moiety. This unique arrangement of functional groups suggests potential interactions with biological targets, making it an attractive scaffold for drug discovery.

In recent years, there has been growing interest in the development of novel compounds that can modulate biological pathways associated with various diseases. The pyridazine core is known for its ability to interact with enzymes and receptors, while the cyclopropane ring introduces rigidity that can enhance binding affinity. The presence of a chlorine substituent further increases the compound's potential for selective interactions.

One of the most compelling aspects of N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride is its potential as a lead compound in the development of therapeutic agents. Preclinical studies have begun to explore its effects on various biological systems, particularly those involving inflammation and pain signaling. The compound's ability to interact with key enzymes such as cyclooxygenases (COX) and lipoxygenases (LOX) has been a focus of attention.

Recent research has highlighted the importance of cyclopropane-containing compounds in medicinal chemistry. These molecules have shown promise in inhibiting enzymes that play a role in inflammatory responses. For instance, studies have demonstrated that derivatives of cyclopropanamines can interfere with the catalytic activity of COX-2, a key enzyme involved in the production of prostaglandins that mediate pain and inflammation.

The chloropyridazine moiety in N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride also contributes to its pharmacological profile. Chlorinated pyridazines are known to exhibit broad-spectrum biological activity, including antimicrobial and anti-inflammatory properties. This makes the compound a versatile tool for investigating new therapeutic strategies.

In vitro studies have provided initial insights into the mechanism of action of this compound. Preliminary data suggest that it can inhibit the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). These findings are particularly intriguing given the high prevalence of chronic inflammatory conditions worldwide.

The synthesis of N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The introduction of the cyclopropane ring is particularly challenging due to its strained three-membered structure. However, advances in synthetic methodologies have made it possible to construct this motif efficiently.

The hydrochloride salt form of this compound enhances its pharmacokinetic properties, making it more suitable for in vivo studies. Solubility is a critical factor in drug development, as it affects absorption, distribution, metabolism, and excretion (ADME) profiles. By forming a hydrochloride salt, researchers can improve solubility while maintaining the compound's biological activity.

Future research will likely focus on exploring the therapeutic potential of N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride in animal models of inflammation and pain. Additionally, computational studies using molecular modeling techniques may help identify new derivatives with enhanced potency and selectivity. These efforts could lead to the discovery of novel drugs that address unmet medical needs.

The integration of computational chemistry with experimental pharmacology has revolutionized drug discovery in recent decades. By leveraging computational tools, researchers can predict the binding modes of small molecules to biological targets, thereby accelerating the identification of lead compounds. This approach has been instrumental in developing drugs that target complex diseases such as cancer and neurodegenerative disorders.

The unique structural features of N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride make it an intriguing candidate for further exploration. Its ability to interact with multiple biological targets suggests potential applications in treating a wide range of conditions. As research continues to uncover new therapeutic strategies, compounds like this one will play an increasingly important role in modern medicine.

• 1420878-54-1(4-N-[(6-Chloropyridazin-3-yl)methyl]cyclohexane-1,4-diamine;hydrochloride)
• 1289386-54-4(N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride)
• 1289386-36-2((6-CHLORO-PYRIDAZIN-3-YLMETHYL)-ISOPROPYL-AMINE)
• 1353977-63-5(N-((6-Chloropyridazin-3-yl)methyl)propan-2-amine hydrochloride)
• 1421038-29-0((3R)-N-[(6-Chloropyridazin-3-yl)methyl]pyrrolidin-3-amine;hydrochloride)
• 1421038-34-7((3S)-N-[(6-Chloropyridazin-3-yl)methyl]pyrrolidin-3-amine;hydrochloride)
• 1420852-98-7(1-((6-Chloropyridazin-3-yl)methyl)-N-methylpiperidin-4-amine hydrochloride)
• 1289386-56-6((6-CHLORO-PYRIDAZIN-3-YLMETHYL)-ETHYL-AMINE)
• 1421025-97-9((3R)-N-[(6-Chloropyridazin-3-yl)methyl]piperidin-3-amine;hydrochloride)
• 1421026-74-5((3S)-N-[(6-Chloropyridazin-3-yl)methyl]piperidin-3-amine;hydrochloride)